MANERIX
Identification of Manerix
| No description |
Google image searchProduct monograph
Active ingredient
moclobemide, 150 MG
DIN: 00899356
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 24-JUN-2021
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06A — ANTIDEPRESSANTS (ATC, ATC/DDD)
- N06AG — Monoamine oxidase A inhibitors (ATC, ATC/DDD)
- N06AG02 — MOCLOBEMIDE (ATC/DDD)
Reference brand drug: Manerix
